Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: 'More needs to be done for inclusion of LGBTQ in workplace

There is a great scope of improvement regarding the inclusion of LGBTQ people in the pharmaceutical sector, panelists said at the Pharmacy Business Diversity Conference during a session on LGBTQ+ Inclusion in the Workplace.

Robbie Turner, director of pharmacy and member experience at the Royal Pharmaceutical Society (RPS), sharing his feedback from others in the profession, said “this wasn't a profession that was welcoming of difference,” adding “the sector needs to improve in this regard.”


Turner, who came out as a gay man at 15 and have been out (openly gay) at work ever since, acknowledged that despite being a senior leader he faces microagression.

“I don't suffer from homophobia, but I do suffer from microaggression even as a senior leader, often from people who are being perfectly nice."

Robbie, who recently adopted two children said people often ask him, “what's the children's mother called? What does your wife do?”.

It is important to “use more open and inclusive language without being detrimental to anybody."

Turner noted that in efforts towards inclusion of LGBTQ+, it is crucial to encourage open conversations about microaggressions and bringing people together to share their experiences of life, he said.

Further, he said that RPS is creating an umbrella network for cultural diversity, “making things better for any group, who feels marginalised. It is going to be helpful for everybody and makes workplaces better.”

“We celebrate people's difference and recognise the benefits in pharmacy.”

The session, moderated by the conference chair BBC presenter Clive Myrie, also had Annie Newman, senior digital content editor at GSK and Bhavik Pancholi, senior manager Diversity & Inclusion at Mundipharma.

Talking about initiatives to promote inclusion at GSK, Newman said the company often shares stories, “letting people know what it's like to work with the GSK as an LGBTQ+ person.”

At GSK there are areas where LGBTQ+ can actively take part and see senior leaders talking about what it's like to be from that group and have mentors from the community to help them feel inclusive, she said.

Besides storytelling the company does “a lot in the background that isn't always visible to employees.”

She added the firm has been working to alter its recruitment process to make it more inclusive like having a diverse recruitment panel, advertising at places where more LGBTQ+ women work.

Also, the company emphasises on using inclusive language in its policies.

Putting more weight behind having open conversations, Pancholi said it is important to speak with the LGBTQ+ community and understand their experiences rather than making assumptions about them.

He said: “Let's remember there are people outside the binary of male and female, so if we don't have a voice, let's still make sure that we are inclusive in the language that we use.”

He added that there are several ways in which allies can show their support towards the LGBTQ+ community for example by including them on their email signatures and by ensuring a safe workplace.

“I think it's important to recognize at work, as having a safe workplace is often a haven for people because life isn't safe.

“Homophobia is on the increase, transphobia is rampant, so people should be able to come to work and feel as safe and as welcome and celebrated as possible."

More For You

How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less